Injective (INJ) is currently priced at $3.61, reflecting a 24-hour decline of 4.12%. The price has fluctuated between a daily high of $3.90 and a low of $3.52, indicating a relatively tight daily range of 0.38%.

The trading volume over the past 24 hours is approximately $74.12 million, which represents 20.50% of the market cap. Moving averages show mixed signals, with the 8 SMA at $3.54 indicating a short-term bullish sentiment (+1.85%), while the 21 SMA at $3.63 and 55 SMA at $3.65 are slightly bearish (-0.42% and -1.04%, respectively).

The 1-hour RSI stands at 45, suggesting the asset is nearing oversold territory, while the 7-day RSI at 54 indicates a neutral position. Price performance over the last week shows a notable gain of 10.07%, with 14-day and 30-day changes at 18.52% and 25.80%, respectively, reflecting a strong upward trend in the medium term.

Despite the current price dip, the fundamental outlook remains positive, with the all-time high of $52.62 indicating significant long-term potential. Given the current technical indicators and the robust recent price performance, a short-term rebound appears plausible.

Considering the mixed signals from moving averages and the recent price action, the recommendation is to Hold. This allows for assessment of potential further price movement while avoiding the risk of short-term volatility.